How effective are common medications: a perspective based on meta-analyses of major drugs
The vastness of clinical data and the progressing specialization of medical knowledge may
lead to misinterpretation of medication efficacy. To show a realistic perspective on drug …
lead to misinterpretation of medication efficacy. To show a realistic perspective on drug …
How good is “evidence” from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs?
H Naci, JPA Ioannidis - Annual review of pharmacology and …, 2015 - annualreviews.org
Promising evidence from clinical studies of drug effects does not always translate to
improvements in patient outcomes. In this review, we discuss why early evidence is often ill …
improvements in patient outcomes. In this review, we discuss why early evidence is often ill …
Interpretation and impact of real-world clinical data for the practicing clinician
Real-world studies have become increasingly important in providing evidence of treatment
effectiveness in clinical practice. While randomized clinical trials (RCTs) are the “gold …
effectiveness in clinical practice. While randomized clinical trials (RCTs) are the “gold …
[HTML][HTML] Interpreting estimates of treatment effects: implications for managed care
SV Faraone - Pharmacy and Therapeutics, 2008 - ncbi.nlm.nih.gov
How should health care professionals choose among the many therapies claimed to be
efficacious for treating specific disorders? The practice of evidence-based medicine …
efficacious for treating specific disorders? The practice of evidence-based medicine …
Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development
Comparative‐effectiveness research (CER) aims to produce actionable evidence regarding
the effectiveness and safety of medical products and interventions as they are used outside …
the effectiveness and safety of medical products and interventions as they are used outside …
Superior efficacy of new medicines?
JCF Van Luijn, FWJ Gribnau, HGM Leufkens - European journal of clinical …, 2010 - Springer
Purpose To provide an overview of and discuss newly authorised medicines with an
improved efficacy. Methods This analysis focussed on new medicines with an improved …
improved efficacy. Methods This analysis focussed on new medicines with an improved …
Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects
JP Vandenbroucke, BM Psaty - Jama, 2008 - jamanetwork.com
THE CENTRAL THEME OF THE INSTITUTE OF MEDICINE report on the US drug safety
system was the need for a life cycle approach to drug evaluation: both the benefits and the …
system was the need for a life cycle approach to drug evaluation: both the benefits and the …
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials
Background There have been ongoing efforts to understand when and how data from
observational studies can be applied to clinical and regulatory decision making. The …
observational studies can be applied to clinical and regulatory decision making. The …
A review of NICE appraisals of pharmaceuticals 2000–2016 found variation in establishing comparative clinical effectiveness
M Anderson, H Naci, D Morrison, L Osipenko… - Journal of clinical …, 2019 - Elsevier
Objective To identify and assess the methods for estimating comparative clinical
effectiveness for novel pharmaceutical products licensed on the basis of nonrandomized …
effectiveness for novel pharmaceutical products licensed on the basis of nonrandomized …
Developments in post‐marketing comparative effectiveness research
S Schneeweiss - Clinical Pharmacology & Therapeutics, 2007 - Wiley Online Library
Physicians and insurers need to weigh the effectiveness of new drugs against existing
therapeutics in routine care to make decisions about treatment and formularies. Because …
therapeutics in routine care to make decisions about treatment and formularies. Because …